Tatva Chintan Pharma Chem (NSE:TATVA) Selling, General, & Admin. Expense: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
81 GF Score
Price ₹1,688.40
GF Value ₹1,524.96
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Selling, General, & Admin. Expense?

Tatva Chintan Pharma Chem NSE:TATVA +0.49% 81 Selling, General, & Admin. Expense is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:TATVA with a GF Score™ of 81/100 and a GF Value™ of ₹1,524.96 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Tatva Chintan Pharma Chem's selling, general, & admin. expense for the three months ended in Jun. 2026 was ₹0 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil.


Tatva Chintan Pharma Chem  (NSE:TATVA) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Tatva Chintan Pharma Chem Selling, General, & Admin. Expense Related Terms


Tatva Chintan Pharma Chem Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Selling, General, & Admin. Expense Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Selling, General, & Admin. Expense
Get a 7-Day Free Trial 374.41 338.33 282.48 316.06 369.67

Tatva Chintan Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:TATVA vs LIN, SHW, ECL: Selling, General, & Admin. Expense Comparison

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem Selling, General, & Admin. Expense vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense falls into.


NSE:TATVA
81GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of ₹0 Mil mean?
Tatva Chintan Pharma Chem (NSE:TATVA) has a Selling, General, & Admin. Expense of ₹0 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense too high?
Tatva Chintan Pharma Chem's current Selling, General, & Admin. Expense is ₹0 Mil. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense compare to LIN and SHW?
Tatva Chintan Pharma Chem's Selling, General, & Admin. Expense of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Chemicals company?
A good Selling, General, & Admin. Expense depends on the Chemicals industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Selling, General, & Admin. Expense is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,524.96, compared to a current price of ₹1,688.40 — trading 10.7% above its estimated fair value. The current Selling, General, & Admin. Expense is ₹0 Mil. Tatva Chintan Pharma Chem's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Selling, General, & Admin. Expense is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued. The current stock price of ₹1,688.40 is trading 10.7% above its estimated GF Value™ of ₹1,524.96. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.

Key valuation signals for NSE:TATVA:

  • Selling, General, & Admin. Expense: ₹0 Mil
  • GF Value™: ₹1,524.96 vs. price of ₹1,688.40 (10.7% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
81GF Score

Get the complete analysis for NSE:TATVA

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,688.40
Price
₹1,524.96
GF Value